Company news
Ocular Therapeutix, Inc. news in 2020
Ocular Therapeutix, Inc.'s news releases, calls and decks from 2020, newest first.
Ocular TherapeutixTM Announces Exercise of Underwriters’ Option to Purchase Additional Shares
December 27, 2020
Ocular Therapeutix™ Announces Submission to the FDA of a Supplemental New Drug Application for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
December 21, 2020
Ocular TherapeutixTM Announces Pricing of Public Offering of Common Stock
December 14, 2020
Ocular Therapeutix™ to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 22, 2020
Ocular Therapeutix™ To Present Data at the American Academy of Ophthalmology (AAO) 2020 Virtual Annual Meeting
November 10, 2020
Ocular Therapeutix™ Reports Third Quarter 2020 Financial Results and Business Update
November 4, 2020
Ocular Therapeutix Announces Receipt of a Permanent Category I CPT Code from the American Medical Association for the Insertion of Intracanalicular Inserts
November 3, 2020
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
October 29, 2020
Ocular Therapeutix™ To Report Third Quarter 2020 Financial Results
October 22, 2020
Ocular Therapeutix™ Announces Topline Phase 1 Clinical Trial Results of OTX-CSI
October 7, 2020
Ocular Therapeutix Announces Preliminary Net Product Revenue of $5.8 Million to $5.9 Million for Third Quarter 2020, Representing Greater Than a 250% Increase Over the Previous Quarter
October 6, 2020
Ocular Therapeutix Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
October 5, 2020
Ocular Therapeutix™ Announces First Patients Dosed in Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease
September 28, 2020
Ocular Therapeutix™ Announces First Patient Dosed in Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Post-Surgical Ocular Inflammation and Pain in Children
September 9, 2020
Ocular Therapeutix™ Announces Successful Resolution of FDA Warning Letter Related to ReSure® Sealant
September 7, 2020
Ocular Therapeutix Announces Third Medicare Administrative Contractor to Establish New Published Physician Fee Schedule for Administration of Intracanalicular Inserts
September 3, 2020
Ocular Therapeutix™ Reports Second Quarter 2020 Financial Results and Business Update
August 6, 2020
Ocular Therapeutix™ To Report Second Quarter 2020 Financial Results
July 30, 2020
Ocular Therapeutix Announces Second Medicare Administrative Contractor to Establish New Published Physician Fee Schedule for Administration of Intracanalicular Inserts
July 22, 2020
Ocular Therapeutix Presents at the 12th Annual Ophthalmology Innovation Summit (OIS)
July 16, 2020
Ocular Therapeutix Announces Its First Published Physician Fee Schedule for Administration of Intracanalicular Inserts
July 14, 2020
Ocular Therapeutix™ to Present Data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
June 14, 2020
Ocular Therapeutix™ to Hold Virtual 2020 Annual Meeting Of Stockholders
June 14, 2020
Ocular Therapeutix™ Announces First Patient Dosed in Phase 1 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease
May 11, 2020
Ocular Therapeutix™ Reports First Quarter 2020 Financial Results and Business Update
May 7, 2020
Ocular Therapeutix™ To Report First Quarter 2020 Financial Results
April 29, 2020
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of DEXTENZA® for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
April 27, 2020
Ocular Therapeutix™ Provides Business Update and Response to COVID-19 Global Pandemic
April 12, 2020
Ocular Therapeutix™ Reports Fourth Quarter and Year End 2019 Financial Results and Business Update
March 11, 2020
Ocular Therapeutix™ To Report Fourth Quarter and Year-End 2019 Financial Results
March 4, 2020
Ocular Therapeutix™ Announces Preliminary Fourth Quarter 2019 Net Product Revenue and Provides Update on Interim Data from the OTX-TKI Phase 1 Clinical Trial at the Cowen 40th Annual Health Care Conference
March 2, 2020
Decks in 2020
- Ophthalmology Innovation Summit (OIS) Virtual Public Company Showcase 2020
Conference · 18 slides · Jul 16, 2020
- Technical Presentation (March 2020)
Technical · 9 slides · Mar 3, 2020